Discount Agreement for Dalbavancin (01.06.2026 - 31.05.2028)
DAK-Gesundheit offers pharmaceutical companies the opportunity to enter into discount agreements for the active ingredient Dalbavancin. This applies to the period from 01.06.2026 to 31.05.2028, with an extension option.
CONTRACTING AUTHORITY
Name
DAK-Gesundheit
City
Hamburg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
1051 days remaining(LOT-0001)
Published